The impact of antithrombotic therapy on surgical delay and 2-year mortality in older patients with hip fracture: a prospective observational study.
Samuel LópezCarmen da CasaCarmen Pablos-HernándezDavid PescadorAgustín Díaz-ÁlvarezNuria AsensioJuan F BlancoPublished in: European geriatric medicine (2020)
Hip fracture patients following previous oral anticoagulant treatment have a higher 2-year mortality rate. The oral anticoagulant or high-dose antiplatelet treatments are significantly associated with an increase in the length of stay, related to time to surgery, but we could not demonstrate an effect on early mortality.
Keyphrases
- hip fracture
- cardiovascular events
- high dose
- atrial fibrillation
- venous thromboembolism
- risk factors
- newly diagnosed
- ejection fraction
- minimally invasive
- low dose
- cardiovascular disease
- coronary artery bypass
- acute coronary syndrome
- patient reported outcomes
- stem cell transplantation
- bone marrow
- cell therapy
- patient reported